206 related articles for article (PubMed ID: 31129707)
41. Melorheostosis: segmental osteopoikilosis or a separate entity?
Kadhim M; Deardorff MA; Dubbs H; Zackai EH; Dormans JP
J Pediatr Orthop; 2015 Mar; 35(2):e13-7. PubMed ID: 25575356
[TBL] [Abstract][Full Text] [Related]
42. Mutation in LEMD3 (Man1) Associated with Osteopoikilosis and Late-Onset Generalized Morphea: A New Buschke-Ollendorf Syndrome Variant.
Korman B; Wei J; Laumann A; Ferguson P; Varga J
Case Rep Dermatol Med; 2016; 2016():2483041. PubMed ID: 27382493
[TBL] [Abstract][Full Text] [Related]
43. Buschke-Ollendorff syndrome associated with hypertrophic scar formation: a possible role for LEMD3 mutation.
Korekawa A; Nakano H; Toyomaki Y; Takiyoshi N; Rokunohe D; Akasaka E; Nakajima K; Sawamura D
Br J Dermatol; 2012 Apr; 166(4):900-3. PubMed ID: 21985280
[No Abstract] [Full Text] [Related]
44. Buschke-Ollendorff syndrome: a manifestation of a heterozygous nonsense mutation in the LEMD3 gene.
Gass JK; Hellemans J; Mortier G; Griffiths M; Burrows NP
J Am Acad Dermatol; 2008 May; 58(5 Suppl 1):S103-4. PubMed ID: 18489034
[No Abstract] [Full Text] [Related]
45. Linear scleroderma and melorheostosis: case presentation and literature review.
Moreno Alvarez MJ; Lázaro MA; Espada G; Barceló HA; Maldonado Cocco A
Clin Rheumatol; 1996 Jul; 15(4):389-93. PubMed ID: 8853175
[TBL] [Abstract][Full Text] [Related]
46. Buschke-Ollendorff syndrome due to a novel LEMD3 mutation - an unusual case of alopecia.
Darr-Foit S; Schliemann S; Schulz S; Elsner P
J Dtsch Dermatol Ges; 2018 Mar; 16(3):348-349. PubMed ID: 29465813
[No Abstract] [Full Text] [Related]
47. RNA recognition motif of LEMD3 as a key player in the pathogenesis of Buschke-Ollendorff syndrome.
Takashima S; Fujita Y; Suzuki S; Saito N; Shinkuma S; Nomura T; Shimizu H
J Dermatol Sci; 2016 Mar; 81(3):205-8. PubMed ID: 26711937
[No Abstract] [Full Text] [Related]
48. [Buschke-Ollendorff syndrome: inactivating mutation of the LEMD3 gene].
Dereure O
Ann Dermatol Venereol; 2005; 132(6-7 Pt 1):593. PubMed ID: 16142115
[No Abstract] [Full Text] [Related]
49. Novel 4-bp Intronic Deletion (c.1560+5_1560+8del) [corrected] in LEMD3 in a Korean Patient With Osteopoikilosis.
Yoo IY; Song JS; Ki CS; Kim JW; Cha HS; Min YK
Ann Lab Med; 2017 Nov; 37(6):540-543. PubMed ID: 28840995
[TBL] [Abstract][Full Text] [Related]
50. Buschke-Ollendorff syndrome: a novel case series and systematic review.
Pope V; Dupuis L; Kannu P; Mendoza-Londono R; Sajic D; So J; Yoon G; Lara-Corrales I
Br J Dermatol; 2016 Apr; 174(4):723-9. PubMed ID: 26708699
[TBL] [Abstract][Full Text] [Related]
51. [Dermatofibrosis lenticularis disseminata with osteopoikilosis (Buschke-Ollendorff syndrome)].
Lippelt C; Petzel H
Radiologe; 1982 Dec; 22(12):553-61. PubMed ID: 7156389
[TBL] [Abstract][Full Text] [Related]
52. LEMD3: the gene responsible for bone density disorders (osteopoikilosis).
Ben-Asher E; Zelzer E; Lancet D
Isr Med Assoc J; 2005 Apr; 7(4):273-4. PubMed ID: 15847215
[No Abstract] [Full Text] [Related]
53. Familial osteopoikilosis.
Boyaci A; Boyaci N; Tutoglu A
J Back Musculoskelet Rehabil; 2013; 26(3):247-50. PubMed ID: 23893138
[TBL] [Abstract][Full Text] [Related]
54. [Osteopoikilosis and melorheostosis].
Buchmann J
Beitr Orthop Traumatol; 1968; 15(11):641-2. PubMed ID: 5733037
[No Abstract] [Full Text] [Related]
55. CT analysis of anatomical distribution of melorheostosis challenges the sclerotome hypothesis.
Jha S; Laucis N; Kim L; Malayeri A; Dasgupta A; Papadakis GZ; Karantanas A; Torres M; Bhattacharyya T
Bone; 2018 Dec; 117():31-36. PubMed ID: 30218789
[TBL] [Abstract][Full Text] [Related]
56. Depressed indurated plaque with elastorrhexis as a distinctive lesion in Buschke-Ollendorff syndrome.
Velasco Huici R; Martín JM; Vázquez B; Silva E; Estébanez A; Cuesta A; Ramón D; Monteagudo C
Pediatr Dermatol; 2020 Mar; 37(2):385-387. PubMed ID: 31943321
[TBL] [Abstract][Full Text] [Related]
57. Mixed sclerosing bone dystrophy with regression of melorheostosis.
Kanis JA; Thomson JG
Br J Radiol; 1975 May; 48(569):400-2. PubMed ID: 1139098
[No Abstract] [Full Text] [Related]
58. [Melorheostosis, osteopoikilosis and linear scleroderma (author's transl)].
Pascaud-Ged E; Rihouet J; Pascaud JL; Rousseau J
Sem Hop; 1982 Apr; 58(17):1056-9. PubMed ID: 6285483
[No Abstract] [Full Text] [Related]
59. Distribution and Functional Consequences of Somatic MAP2K1 Variants in Affected Skin Associated with Bone Lesions in Melorheostosis.
Jha S; Ivovic A; Kang H; Meylan F; Hanson EP; Rimland C; Lange E; Katz J; McBride A; Warner AC; Edmondson EF; Cowen EW; Marini JC; Siegel RM; Bhattacharyya T
J Invest Dermatol; 2021 Mar; 141(3):688-692.e11. PubMed ID: 32791068
[No Abstract] [Full Text] [Related]
60. Mixed sclerosing bone dystrophy presenting with upper extremity deformities. A case report and review of the literature.
Ostrowski DM; Gilula LA
J Hand Surg Br; 1992 Feb; 17(1):108-12. PubMed ID: 1640136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
